B-Organ	0	11	Oesophageal	Oesophageal	JJ	B-NP
O	12	23	candidiasis	candidiasis	NN	I-NP
O	24	27	and	and	CC	I-NP
O	28	33	croup	croup	NN	I-NP
O	34	36	in	in	IN	B-PP
O	37	38	a	a	DT	B-NP
O	39	44	child	child	NN	I-NP
O	45	49	with	with	IN	B-PP
O	50	59	defective	defective	JJ	B-NP
B-Cell	60	70	neutrophil	neutrophil	NN	I-NP
O	71	79	motility	motility	NN	I-NP
O	79	80	.	.	.	O

O	81	87	Severe	Severe	JJ	B-NP
B-Organ	88	99	oesophageal	oesophageal	JJ	I-NP
O	100	111	candidiasis	candidiasis	NN	I-NP
O	112	115	and	and	CC	I-NP
O	116	121	croup	croup	NN	I-NP
O	122	125	due	due	JJ	B-ADJP
O	126	128	to	to	TO	B-PP
O	129	140	involvement	involvement	NN	B-NP
O	141	143	of	of	IN	B-PP
O	144	147	the	the	DT	B-NP
B-Multi-tissue_structure	148	154	larynx	larynx	NN	I-NP
O	155	164	developed	develop	VBD	B-VP
O	165	176	insidiously	insidiously	RB	B-ADVP
O	177	179	in	in	IN	B-PP
O	180	181	a	a	DT	B-NP
O	182	186	girl	girl	NN	I-NP
O	187	191	aged	age	VBN	B-VP
O	192	194	20	20	CD	B-NP
O	195	201	months	month	NNS	I-NP
O	201	202	.	.	.	O

O	203	208	There	There	EX	B-NP
O	209	212	had	have	VBD	B-VP
O	213	217	been	be	VBN	I-VP
O	218	225	delayed	delay	VBN	I-VP
O	226	236	separation	separation	NN	B-NP
O	237	239	of	of	IN	B-PP
O	240	243	the	the	DT	B-NP
B-Multi-tissue_structure	244	253	umbilical	umbilical	JJ	I-NP
I-Multi-tissue_structure	254	258	cord	cord	NN	I-NP
O	259	262	and	and	CC	O
O	263	271	repeated	repeat	VBN	B-NP
O	272	282	infections	infection	NNS	I-NP
O	283	293	associated	associate	VBN	B-VP
O	294	298	with	with	IN	B-PP
O	299	300	a	a	DT	B-NP
O	301	307	defect	defect	NN	I-NP
O	308	310	of	of	IN	B-PP
B-Cell	311	321	neutrophil	neutrophil	NN	B-NP
O	322	330	motility	motility	NN	I-NP
O	330	331	.	.	.	O

O	332	335	The	The	DT	B-NP
O	336	348	significance	significance	NN	I-NP
O	349	351	of	of	IN	B-PP
O	352	355	the	the	DT	B-NP
O	356	361	early	early	JJ	I-NP
O	362	370	clinical	clinical	JJ	I-NP
O	371	379	features	feature	NNS	I-NP
O	380	383	was	be	VBD	B-VP
O	384	387	not	not	RB	I-VP
O	388	393	fully	fully	RB	I-VP
O	394	405	appreciated	appreciate	VBN	I-VP
O	406	409	and	and	CC	O
O	410	413	the	the	DT	B-NP
O	414	423	diagnosis	diagnosis	NN	I-NP
O	424	434	considered	consider	VBN	B-VP
O	435	439	only	only	RB	B-ADVP
O	440	444	when	when	WRB	I-ADVP
O	445	454	stricture	stricture	NN	B-NP
O	455	457	of	of	IN	B-PP
O	458	461	the	the	DT	B-NP
B-Organ	462	472	oesophagus	oesophagus	NN	I-NP
O	473	479	became	become	VBD	B-VP
O	480	487	evident	evident	JJ	B-ADJP
O	487	488	.	.	.	O

O	489	492	She	She	PRP	B-NP
O	493	496	was	be	VBD	B-VP
O	497	504	treated	treat	VBN	I-VP
O	505	509	with	with	IN	B-PP
B-Organism_subdivision	510	514	oral	oral	JJ	B-NP
O	515	527	ketoconazole	ketoconazole	NN	I-NP
O	528	531	100	100	CD	I-NP
O	532	534	mg	mg	NN	I-NP
O	535	540	daily	daily	RB	B-ADVP
O	540	541	.	.	.	O

O	542	547	After	After	IN	B-PP
O	548	551	one	one	CD	B-NP
O	552	557	month	month	NN	I-NP
O	557	558	'	'	POS	B-NP
O	558	559	s	s	NN	I-NP
O	560	569	treatment	treatment	NN	I-NP
O	570	575	there	there	EX	B-NP
O	576	579	was	be	VBD	B-VP
O	580	588	striking	striking	JJ	B-NP
O	589	601	radiological	radiological	JJ	I-NP
O	602	613	improvement	improvement	NN	I-NP
O	614	619	apart	apart	RB	B-ADVP
O	620	624	from	from	IN	B-PP
O	625	628	the	the	DT	B-NP
O	629	640	persistence	persistence	NN	I-NP
O	641	643	of	of	IN	B-PP
O	644	647	the	the	DT	B-NP
B-Organ	648	659	oesophageal	oesophageal	JJ	I-NP
O	660	669	stricture	stricture	NN	I-NP
O	669	670	.	.	.	O

O	671	674	The	The	DT	B-NP
O	675	680	croup	croup	NN	I-NP
O	681	689	resolved	resolve	VBD	B-VP
O	690	700	completely	completely	RB	B-ADVP
O	701	704	but	but	CC	O
O	705	710	there	there	RB	B-NP
O	711	714	was	be	VBD	B-VP
O	715	719	only	only	RB	B-NP
O	720	727	partial	partial	JJ	I-NP
O	728	734	relief	relief	NN	I-NP
O	735	737	of	of	IN	B-PP
O	738	747	dysphagia	dysphagia	NN	B-NP
O	748	755	because	because	IN	B-PP
O	756	758	of	of	IN	I-PP
O	759	762	the	the	DT	B-NP
O	763	771	residual	residual	JJ	I-NP
O	772	781	stricture	stricture	NN	I-NP
O	781	782	.	.	.	O

O	783	785	We	We	PRP	B-NP
O	786	791	would	would	MD	B-VP
O	792	800	emphasis	emphasis	VB	I-VP
O	801	805	that	that	DT	B-NP
O	806	817	candidiasis	candidiasis	NN	I-NP
O	818	824	should	should	MD	B-VP
O	825	827	be	be	VB	I-VP
O	828	839	anticipated	anticipate	VBN	I-VP
O	840	843	and	and	CC	O
O	844	851	treated	treat	VBN	B-VP
O	852	862	vigorously	vigorously	RB	B-ADVP
O	863	865	in	in	IN	B-PP
O	866	874	children	child	NNS	B-NP
O	875	879	with	with	IN	B-PP
O	880	884	such	such	PDT	B-NP
O	885	886	a	a	DT	I-NP
O	887	893	defect	defect	NN	I-NP
O	894	896	of	of	IN	B-PP
B-Cell	897	907	neutrophil	neutrophil	NN	B-NP
O	908	916	motility	motility	NN	I-NP
O	916	917	.	.	.	O

